Hepatitis B virus X‐interacting protein (HBXIP) is upregulated in liver cancer tissues and mediates the METTL3‐induced metabolic reprogramming and malignant behavior of HCC cells, accelerating tumor progression.165. Here, METTL3 is linked to hepatocellular carcinoma.